Almuradova D.M.

1 ta ish

PhD, Associate Professor, Department of Oncology, Oncohematology and Radiation Oncology, Tashkent State Medical University, Uzbekistan

1. Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis

   Almuradova D.M., Ravshanova . N.B, Abdurakhimov A.I.

   MaqolaLung Cancer Treatments and MutationsInternational Journal of Medical Sciences And Clinical Research20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.011903